HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth

Abstract : no abstract
Document type :
Journal articles
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-01614947
Contributor : Lionel Spinelli Connect in order to contact the contributor
Submitted on : Wednesday, October 11, 2017 - 4:49:19 PM
Last modification on : Wednesday, January 19, 2022 - 2:10:02 PM

Links full text

Identifiers

Collections

Citation

Coralie Hoareau-Aveilla, Thibaud Valentin, Camille Daugrois, Cathy Quelen, Géraldine Mitou, et al.. Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth. Journal of Clinical Investigation, American Society for Clinical Investigation, 2015, 125 (9), pp.3505--3518. ⟨10.1172/JCI78488⟩. ⟨hal-01614947⟩

Share

Metrics

Record views

53